TY - JOUR
T1 - Complement System in Brain Architecture and Neurodevelopmental Disorders
AU - Magdalon, Juliana
AU - Mansur, Fernanda
AU - Teles e Silva, Andre Luiz
AU - de Goes, Vitor Abreu
AU - Reiner, Orly
AU - Sertie, Andrea Laurato
N1 - This work was supported by São Paulo Research Foundation (FAPESP) (Grant No. 2015/50138-4), Helen and Martin Kimmel Institute for Stem Cell Research, Nella and Leon Benoziyo Center for Neurological Diseases, David and Fela Shapell Family Center for Genetic Disorders Research, Brenden-Mann Women’s Innovation Impact Fund, Richard F. Goodman Yale/Weizmann Exchange Program, The Irving B. Harris Fund for New Directions in Brain Research, Irving Bieber, M.D. and Toby Bieber, M.D. Memorial Research Fund, Leff Family Barbara & Roberto Kaminitz, Sergio & Sônia Lozinsky Debbie Koren Jack and Lenore Lowenthal, and Dears Foundation. OR was supported by the Israel Science Foundation (Grant No. 347/15) and the ISF-NSFC Joint Research Program (Grant No. 2449/16). OR is an Incumbent of the Bernstein-Mason Professorial Chair of Neurochemistry and Head of the M. Judith Ruth Institute for Preclinical Brain Research.
PY - 2020/2/5
Y1 - 2020/2/5
N2 - Current evidence indicates that certain immune molecules such as components of the complement system are directly involved in neurobiological processes related to brain development, including neurogenesis, neuronal migration, synaptic remodeling, and response to prenatal or early postnatal brain insults. Consequently, complement system dysfunction has been increasingly implicated in disorders of neurodevelopmental origin, such as schizophrenia, autism spectrum disorder (ASD) and Rett syndrome. However, the mechanistic evidence for a causal relationship between impaired complement regulation and these disorders varies depending on the disease involved. Also, it is still unclear to what extent altered complement expression plays a role in these disorders through inflammation-independent or -dependent mechanisms. Furthermore, pathogenic mutations in specific complement components have been implicated in the etiology of 3MC syndrome, a rare autosomal recessive developmental disorder. The aims of this review are to discuss the current knowledge on the roles of the complement system in sculpting brain architecture and function during normal development as well as after specific inflammatory insults, such as maternal immune activation (MIA) during pregnancy, and to evaluate the existing evidence associating aberrant complement with developmental brain disorders.
AB - Current evidence indicates that certain immune molecules such as components of the complement system are directly involved in neurobiological processes related to brain development, including neurogenesis, neuronal migration, synaptic remodeling, and response to prenatal or early postnatal brain insults. Consequently, complement system dysfunction has been increasingly implicated in disorders of neurodevelopmental origin, such as schizophrenia, autism spectrum disorder (ASD) and Rett syndrome. However, the mechanistic evidence for a causal relationship between impaired complement regulation and these disorders varies depending on the disease involved. Also, it is still unclear to what extent altered complement expression plays a role in these disorders through inflammation-independent or -dependent mechanisms. Furthermore, pathogenic mutations in specific complement components have been implicated in the etiology of 3MC syndrome, a rare autosomal recessive developmental disorder. The aims of this review are to discuss the current knowledge on the roles of the complement system in sculpting brain architecture and function during normal development as well as after specific inflammatory insults, such as maternal immune activation (MIA) during pregnancy, and to evaluate the existing evidence associating aberrant complement with developmental brain disorders.
UR - http://www.scopus.com/inward/record.url?scp=85079682585&partnerID=8YFLogxK
U2 - 10.3389/fnins.2020.00023
DO - 10.3389/fnins.2020.00023
M3 - مقالة مرجعية
SN - 1662-4548
VL - 14
JO - Frontiers in Neuroscience
JF - Frontiers in Neuroscience
M1 - 23
ER -